Department of Molecular and Cellular Pharmacology, Tokyo University of Pharmacy and Life Sciences, 1432-1, Horinouchi, Hachioji, Tokyo 192-0392, Japan.
Cardiovasc Res. 2010 Jul 1;87(1):187-94. doi: 10.1093/cvr/cvq034. Epub 2010 Jan 29.
By examining vasopressin V1a receptor (V1aR) knockout (KO) mice, we previously found that the V1aR is critically involved in the regulation of normal blood pressure. The present study was undertaken to elucidate the role of the V1aR in salt-induced hypertension.
We compared haemodynamic responses induced by subtotal nephrectomy + salt loading in V1aR KO mice with those of wild-type (WT) controls. The time course of changes in the systolic blood pressure and heart rate during the salt loading was attenuated in the KO mice compared with that for the WT mice. The elevation of the plasma norepinephrine level caused by the subtotal nephrectomy + salt loading was also reduced in the V1aR KO mice. A V1aR antagonist markedly lowered the arterial blood pressure in the salt-loaded WT mice but not in the normotensive WT mice or in the salt-loaded or normotensive V1aR KO mice. Whereas arginine vasopressin (AVP) administered to the lateral ventricle of the brain induced pressor and tachycardiac responses accompanied by sympathetic activation in the WT mice, these events were completely abolished in the V1aR KO mice. Also, pressor and tachycardiac responses induced by intraventricularly administered hypertonic saline in the WT mice were diminished in the V1aR KO mice. Moreover, the pressor response induced by intraventricularly administered AVP was reduced in alpha(1d) adrenoceptor KO mice, whereas the tachycardiac response did not differ from that of the WT mice.
These results suggest that the V1aR is involved in the elevation of arterial blood pressure caused by dietary salt and that a V1aR antagonist, in particular regarding its effect in the brain, could have significant therapeutic potential in the treatment of hypertension.
通过研究血管加压素 V1a 受体 (V1aR) 敲除 (KO) 小鼠,我们先前发现 V1aR 对于正常血压的调节至关重要。本研究旨在阐明 V1aR 在盐诱导高血压中的作用。
我们比较了 V1aR KO 小鼠和野生型 (WT) 对照小鼠在部分肾切除+盐负荷诱导的血流动力学反应。与 WT 小鼠相比,KO 小鼠的盐负荷期间收缩压和心率变化的时间进程减弱。部分肾切除+盐负荷引起的血浆去甲肾上腺素水平升高也在 V1aR KO 小鼠中降低。V1aR 拮抗剂在盐负荷 WT 小鼠中显著降低动脉血压,但在正常血压 WT 小鼠或盐负荷或正常血压 V1aR KO 小鼠中则没有。虽然血管加压素 (AVP) 给药于 WT 小鼠的侧脑室可引起升压和心动过速反应,并伴有交感神经激活,但这些事件在 V1aR KO 小鼠中完全被消除。此外,WT 小鼠脑室注射高渗盐水诱导的升压和心动过速反应在 V1aR KO 小鼠中减弱。此外,脑室给予 AVP 诱导的升压反应在 alpha(1d)肾上腺素能受体 KO 小鼠中降低,而心动过速反应与 WT 小鼠没有差异。
这些结果表明 V1aR 参与了饮食盐引起的动脉血压升高,V1aR 拮抗剂,特别是其在大脑中的作用,在治疗高血压方面可能具有显著的治疗潜力。